Researcher Volkan Sayin working on a computer — Photo: Johan Wingborg

Volkan Sayin granted by the Swedish Cancer Society

Published

24 November 2020

at

The Wallenberg Centre for Molecular and Translational Medicine

Volkan Sayin has been awarded SEK 2.4 million from the Swedish Cancer Society. His project is about a platform for defining tumor-specific metabolic Achilles heels for individualized treatment of KRAS-driven non-small cell lung cancer.

Twenty-seven researchers at the University of Gothenburg have together received just over SEK 68 million for various research projects from the Swedish Cancer Society.

About Volkan Sayin Group

The Sayin lab is positioned in the intersection between lung cancer therapeutics, cancer metabolism and redox biology. We are building a precision medicine platform combining the latest technologies in lung cancer research and metabolomics to establish an extensive translational lung cancer group at Sahlgrenska Center for Cancer Research.

Volkan Sayin Group website

More information

Full news article

About the Swedish cancer society

Read the complete list of grant recipients on the Swedish Cancer Society’s website

Area

Health and medicine